(Date:12/3/2009)... JourneyLite of Houston, LLC announced today that it ... surgical option, vertical sleeve gastrectomy , along with ... The first sleeve gastrectomy procedure at the facility was ... on October 20, 2009. The patient is reported ...
(Date:12/3/2009)... SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... last patient visit in its Phase 2 FDG-PET clinical ... 52 patients and was carried out at five sites ...
(Date:12/3/2009)... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... health at home through the merger of rapid diagnostics and ... on its Series B Convertible Perpetual Preferred Stock ( IMA-PB). ... stock in an amount per share equal to the quotient ...
(Date:12/2/2009)... Biosciences Corporation (Nasdaq: MATK ) announced today that it ... fiscal year 2009 on December 16, 2009, at approximately 4:00 ... p.m. ET Martek will conduct a conference call to discuss ... to the call live via webcast by visiting Martek,s web ...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2... promising new technique has been developed that will ... imaging of new cells injected into the body, ... The new technique, which involves engineering antibody fragments ... cells of interest for PET imaging purposescould significantly ...
... The Ensign,Group, Inc. (Nasdaq: ENSG ), the parent ... services and assisted living,companies, announced today that its Board ... per share of Ensign common stock, payable,on or before ... June 30, 2008.,Ensign has been a dividend-paying company since ...
... Line, PARSIPPANY, N.J., June 16 ... on nephrology and endocrinology,announced today that it ... ROCALTROL is a vitamin D analog prescribed ... resultant,metabolic bone disease in patients with moderate ...
Other Biology Technology:New molecular imaging techniques may lead to advances in disease treatment 2The Ensign Group Declares Quarterly Dividend 2Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc. 2Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
... to MSY2/YBOX2 ( Abpromise for ... Antigen: Synthetic peptide derived from ... of Human MSY2/YBOX2. (Note: the ... (Peptide available as ...
Request Info...
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
Biology Products: